About this item:

65 Views | 40 Downloads

Author Notes:

Hans E. Grossniklaus, MD, MBA. Department of Ophthalmology, Emory University, 1365B Clifton Road, Atlanta, GA 30322, USA. Email: ophtheg@emory.edu

(I) Conception and design: OE Uner, HE Grossniklaus; (II) Administrative support: HE Grossniklaus; (III) Provision of study materials or patients: HE Grossniklaus; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.

The authors would like to thank the Journal of Veterinary Science for providing Figure 1, the International Journal of Clinical Oncology for providing Figures 3,​,4,4, and Ocular Oncology and Pathology for providing Figure 5.

All authors have completed the ICMJE uniform disclosure form (available at https://dx.doi.org/10.21037/aes-21-30). The series “Preclinical Models in Ophthalmic Research” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.

Subjects:

Research Funding:

This work was supported by National Institutes of Health, National Eye Institute, NIH NEI P30 06360 and by an unrestricted departmental grant to the Emory Eye Center from Research to Prevent Blindness (New York, NY).

Keywords:

  • Uveal melanoma (UM)
  • animal model
  • ocular melanoma
  • transgenic mice
  • xenograft

Animal models of uveal melanoma

Tools:

Journal Title:

Annals of Eye Science

Volume:

Volume 7

Publisher:

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Animal models are crucial for the study of tumorigenesis and therapies in oncology research. Though rare, uveal melanoma (UM) is the most common intraocular tumor and remains one of the most lethal cancers. Given the limitations of studying human UM cells in vitro, animal models have emerged as excellent platforms to investigate disease onset, progression, and metastasis. Since Greene's initial studies on hamster UM, researchers have dramatically improved the array of animal models. Animals with spontaneous tumors have largely been replaced by engrafted and genetically engineered models. Inoculation techniques continue to be refined and expanded. Newer methods for directed mutagenesis have formed transgenic models to reliably study primary tumorigenesis. Human UM cell lines have been used to generate rapidly growing xenografts. Most recently, patient-derived xenografts have emerged as models that closely mimic the behavior of human UM. Separate animal models to study metastatic UM have also been established. Despite the advancements, the prognosis has only recently improved for UM patients, especially in patients with metastases. There is a need to identify and evaluate new preclinical models. To accomplish this goal, it is important to understand the origin, methods, advantages, and disadvantages of current animal models. In this review, the authors present current and historic animal models for the experimental study of UM. The strengths and shortcomings of each model are discussed and potential future directions are explored.

Copyright information:

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/rdf).
Export to EndNote